APA

Berdelou A., Borget I., Godbert Y., Nguyen T., Garcia M., Chougnet C. N., Ferru A., Buffet C., Chabre O., Huillard O., Leboulleux S. & Schlumberger M. (2018). Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice. : Thyroid : official journal of the American Thyroid Association.

Chicago

Berdelou Amandine, Borget Isabelle, Godbert Yann, Nguyen Thierry, Garcia Marie-Eve, Chougnet Cécile N, Ferru Aurélie, Buffet Camille, Chabre Olivier, Huillard Olivier, Leboulleux Sophie and Schlumberger Martin. 2018. Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice. : Thyroid : official journal of the American Thyroid Association.

Harvard

Berdelou A., Borget I., Godbert Y., Nguyen T., Garcia M., Chougnet C. N., Ferru A., Buffet C., Chabre O., Huillard O., Leboulleux S. and Schlumberger M. (2018). Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice. : Thyroid : official journal of the American Thyroid Association.

MLA

Berdelou Amandine, Borget Isabelle, Godbert Yann, Nguyen Thierry, Garcia Marie-Eve, Chougnet Cécile N, Ferru Aurélie, Buffet Camille, Chabre Olivier, Huillard Olivier, Leboulleux Sophie and Schlumberger Martin. Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice. : Thyroid : official journal of the American Thyroid Association. 2018.